Corrigendum to "Behavioral responses of dopamine β-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action" (DOI:10.1016/j.pbb.2008.07.014);Behavioral responses of dopamine β-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 2, 2008, Pages 217-222

  Mitchell, Heather A ^a   Bogenpohl, James W ^a   Liles, L Cameron ^a   Epstein, Michael P ^a   Bozyczko Coyne, Donna ^b   Williams, Michael ^b   Weinshenker, David ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEPHALON INC   (United States)

Author keywords

Dopamine; Dopamine hydroxylase; Locomotion; Modafinil; Norepinephrine; Sleep

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; MODAFINIL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; AROUSAL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; LOCOMOTION; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SCORING SYSTEM; SIGNAL TRANSDUCTION; SLEEP; WAKEFULNESS;

MUS;

EID: 54349087971     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.12.001     Document Type: Erratum

References (50)

1. Ballon J.S., and Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry 67 (2006) 554-566
2. Bealer S.L. Histamine releases norepinephrine in the paraventricular nucleus/anterior hypothalamus of the conscious rat. J Pharmacol Exp Ther 264 (1993) 734-738
3. Berridge C.W. Neural substrates of psychostimulant-induced arousal. Neuropsychopharmacology 31 (2006) 2332-2340
4. Berridge C.W., and O'Neill J. Differential sensitivity to the wake-promoting actions of norepinephrine within the medial preoptic area and the substantia innominata. Behav Neurosci 115 (2001) 165-174
5. Berridge C.W., Isaac S.O., and Espana R.A. Additive wake-promoting actions of medial basal forebrain noradrenergic alpha1- and beta-receptor stimulation. Behav Neurosci 117 (2003) 350-359
6. Bourdelat-Parks B.N., Anderson G.M., Donaldson Z.R., Weiss J.M., Bonsall R.W., Emery M.S., et al. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice. Psychopharmacology (Berl) 183 (2005) 72-80
7. Colten, H.R., Altevogt, B., Sleep disorders and sleep deprivation: an unmet public health problem. In: Committee on Sleep Medicine and Research, IoMotNA, editor. Washington, D.C.: The National Academies Press, 2006.
8. de Saint Hilaire Z., Orosco M., Rouch C., Blanc G., and Nicolaidis S. Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats. NeuroReport 12 (2001) 3533-3537
9. Delfs J.M., Zhu Y., Druhan J.P., and Aston-Jones G.S. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res 806 (1998) 127-140
10. Drouin C., Blanc G., Trovero F., Glowinski J., and Tassin J.P. Cortical alpha 1-adrenergic regulation of acute and sensitized morphine locomotor effects. NeuroReport 12 (2001) 3483-3486
11. Duteil J., Rambert F.A., Pessonnier J., Hermant J.F., Gombert R., and Assous E. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 180 (1990) 49-58
12. Dzirasa K., Ribeiro S., Costa R., Santos L.M., Lin S.C., Grosmark A., et al. Dopaminergic control of sleep-wake states. J Neurosci 26 (2006) 10577-10589
13. Edgar D.M., and Seidel W.F. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J Pharmacol Exp Ther 283 (1997) 757-769
14. Engber T.M., Dennis S.A., Jones B.E., Miller M.S., and Contreras P.C. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine. Neuroscience 87 (1998) 905-911
15. Engber T.M., Koury E.J., Dennis S.A., Miller M.S., Contreras P.C., and Bhat R.V. Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 241 (1998) 95-98
16. Fritschy J.M., and Grzanna R. Experimentally-induced neuron loss in the locus coeruleus of adult rats. Exp Neurol 111 (1991) 123-127
17. Gallopin T., Luppi P.H., Rambert F.A., Frydman A., and Fort P. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep 27 (2004) 19-25
18. Hermant J.F., Rambert F.A., and Duteil J. Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration. Psychopharmacology (Berl) 103 (1991) 28-32
19. Hunsley M.S., and Palmiter R.D. Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine. Sleep 26 (2003) 521-526
20. Hunsley M.S., and Palmiter R.D. Altered sleep latency and arousal regulation in mice lacking norepinephrine. Pharmacol Biochem Behav 78 (2004) 765-773
21. Isaac S.O., and Berridge C.W. Wake-promoting actions of dopamine D1 and D2 receptor stimulation. J Pharmacol Exp Ther 307 (2003) 386-394
22. Ishizuka T., Sakamoto Y., Sakurai T., and Yamatodani A. Modafinil increases histamine release in the anterior hypothalamus of rats. Neurosci Lett 339 (2003) 143-146
23. Jones B.E., Halaris A.E., McIlhany M., and Moore R.Y. Ascending projections of the locus coeruleus in the rat. I. Axonal transport in central noradrenaline neurons. Brain Res 127 (1977) 1-21
24. Jones L.S., Gauger L.L., and Davis J.N. Anatomy of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]-heat. J Comp Neurol 231 (1985) 190-208
25. Lin J.S., Roussel B., Akaoka H., Fort P., Debilly G., and Jouvet M. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 591 (1992) 319-326
26. Lin J.S., Hou Y., and Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci U S A 93 (1996) 14128-14133
27. Lin J.S., Dauvilliers Y., Arnulf I., Bastuji H., Anaclet C., Parmentier R., et al. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis 30 (2008) 74-83
28. Lu J., Jhou T.C., and Saper C.B. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci 26 (2006) 193-202
29. Madras B.K., Xie Z., Lin Z., Jassen A., Panas H., Lynch L., et al. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 319 (2006) 561-569
30. Mignot E., Nishino S., Guilleminault C., and Dement W.C. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17 (1994) 436-437
31. Minzenberg M.J., and Carter C.S. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33 (2008) 1477-1502
32. Mitchell H.A., Ahern T.H., Liles L.C., Javors M.A., and Weinshenker D. The effects of norepinephrine transporter inactivation on locomotor activity in mice. Biol Psychiatry 60 (2006) 1046-1052
33. Pieribone V.A., Nicholas A.P., Dagerlind A., and Hokfelt T. Distribution of alpha 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J Neurosci 14 (1994) 4252-4268
34. Prast H., Heistracher M., and Philippu A. In vivo modulation of the histamine release in the hypothalamus by adrenoreceptor agonists and antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 344 (1991) 183-186
35. Rommelfanger K.S., Edwards G.L., Freeman K.G., Liles L.C., Miller G.W., and Weinshenker D. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc Natl Acad Sci U S A 104 (2007) 13804-13809
36. Scammell T.E., Estabrooke I.V., McCarthy M.T., Chemelli R.M., Yanagisawa M., Miller M.S., et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 20 (2000) 8620-8628
37. Schank J.R., Ventura R., Puglisi-Allegra S., Alcaro A., Cole C.D., Liles L.C., et al. Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine. Neuropsychopharmacology 31 (2006) 2221-2230
38. Simon P., Hemet C., Ramassamy C., and Costentin J. Non-amphetaminic mechanism of stimulant locomotor effect of modafinil in mice. Eur Neuropsychopharmacol 5 (1995) 509-514
39. Stone E.A., Cotecchia S., Lin Y., and Quartermain D. Role of brain alpha 1B-adrenoceptors in modafinil-induced behavioral activity. Synapse 46 (2002) 269-270
40. Thomas S.A., Matsumoto A.M., and Palmiter R.D. Noradrenaline is essential for mouse fetal development. Nature 374 (1995) 643-646
41. Thomas S.A., Marck B.T., Palmiter R.D., and Matsumoto A.M. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem 70 (1998) 2468-2476
42. Vaughan C.W., Bandler R., and Christie M.J. Differential responses of lateral and ventrolateral rat periaqueductal grey neurones to noradrenaline in vitro. J Physiol 490 Pt 2 (1996) 373-381
43. Weinshenker D., and Schroeder J.P. There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32 (2007) 1433-1451
44. Weinshenker D., Miller N.S., Blizinsky K., Laughlin M.L., and Palmiter R.D. Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proc Natl Acad Sci U S A 99 (2002) 13873-13877
45. Weinshenker D., White S.S., Javors M.A., Palmiter R.D., and Szot P. Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo. Brain Res 946 (2002) 239-246
46. Wilkes S. Bupropion. Drugs Today (Barc) 42 (2006) 671-681
47. Wisor J.P., and Eriksson K.S. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132 (2005) 1027-1034
48. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., and Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 21 (2001) 1787-1794
49. Woulfe J.M., Flumerfelt B.A., and Hrycyshyn A.W. Efferent connections of the A1 noradrenergic cell group: a DBH immunohistochemical and PHA-L anterograde tracing study. Exp Neurol 109 (1990) 308-322
50. Zhang W.P., Ouyang M., and Thomas S.A. Potency of catecholamines and other l-tyrosine derivatives at the cloned mouse adrenergic receptors. Neuropharmacology 47 (2004) 438-449